CBD Insights Explained
CBD, a non-psychoactive component of cannabis, is gaining traction for its potential therapeutic benefits, particularly in anxiety management and as an alternative to opioids. Despite its popularity and ongoing research, the FDA remains cautious, stating that safety conclusions about CBD cannot yet be made. Currently, only one FDA-approved CBD drug exists, targeting specific childhood epilepsy disorders.In this clip
From this podcast
Short Wave
Is CBD Safe? The FDA Can't Say
Related Questions